What is the recommended treatment for an adult patient with cellulitis, considering severity and potential penicillin allergy?

Cellulitis Diagnosis and Treatment

Diagnosis

Cellulitis is diagnosed clinically by the presence of expanding erythema, warmth, tenderness, and swelling of the deep dermis and subcutaneous tissue. 1

Key Diagnostic Features

• Patients typically report preceding skin trauma (minor abrasion, insect bite, or injection site) that served as the portal of entry 2
• Measure and document the extent of erythema, warmth, and surrounding induration to track progression or improvement 2
• No effective laboratory or imaging modalities exist for routine diagnosis—the diagnosis is primarily clinical 1

Critical Exclusion: Rule Out Abscess

• Assess for abscess with ultrasound if there is any clinical uncertainty, as purulent collections require incision and drainage plus MRSA-active antibiotics, not antibiotics alone 2
• The distinction between cellulitis and purulent collections is clinically crucial: cellulitis requires antibiotics as primary treatment, while purulent collections require drainage with antibiotics having only a subsidiary role 2

Warning Signs Requiring Immediate Surgical Consultation

• Severe pain out of proportion to examination findings, skin anesthesia, rapid progression, or "wooden-hard" subcutaneous tissues suggest necrotizing fasciitis and require emergent surgical evaluation 2
• Systemic toxicity with hypotension, altered mental status, or organ dysfunction mandates immediate surgical consultation 2

---

First-Line Antibiotic Treatment

For typical uncomplicated nonpurulent cellulitis, beta-lactam monotherapy is the standard of care and is successful in 96% of patients. 2, 3

Recommended Oral Agents (Choose One)

• Cephalexin 500 mg orally every 6 hours (preferred first-line beta-lactam) 2, 3
• Dicloxacillin 250-500 mg orally every 6 hours 2, 3
• Amoxicillin (appropriate dosing per severity) 2, 3
• Amoxicillin-clavulanate 875/125 mg twice daily 2, 3
• Penicillin V 250-500 mg orally four times daily 2

Treatment Duration

Treat for exactly 5 days if clinical improvement has occurred; extend only if symptoms have not improved within this timeframe. 2, 3 This recommendation is based on high-quality randomized controlled trial evidence showing that 5-day courses are as effective as 10-day courses for uncomplicated cellulitis 2, 4

Why Beta-Lactam Monotherapy Works

• MRSA is an uncommon cause of typical cellulitis, even in hospitals with high MRSA prevalence 2
• When organisms are identified in cellulitis (only 15-20% of cases), most are β-hemolytic streptococci or methicillin-sensitive S. aureus 2, 1
• Beta-lactam treatment is successful in 96% of patients, confirming that MRSA coverage is usually unnecessary 2

---

When to Add MRSA Coverage

Add MRSA-active antibiotics ONLY when specific risk factors are present:

MRSA Risk Factors 2, 3

• Penetrating trauma or injection drug use
• Purulent drainage or exudate
• Evidence of MRSA infection elsewhere or known MRSA colonization
• Systemic inflammatory response syndrome (SIRS)
• Failure to respond to beta-lactam therapy after 48 hours

MRSA-Active Regimens (When Risk Factors Present)

For patients requiring MRSA coverage, choose one of these options:

Option 1: Clindamycin Monotherapy (Preferred if Local Resistance <10%)

• Clindamycin 300-450 mg orally every 6 hours for 5 days 2, 3
• Provides single-agent coverage for both streptococci and MRSA, eliminating the need for combination therapy 2
• Use only if local MRSA clindamycin resistance rates are <10% 2

Option 2: Combination Therapy

• Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily PLUS a beta-lactam (cephalexin or dicloxacillin) 2, 3
• Doxycycline 100 mg orally twice daily PLUS a beta-lactam 2, 3, 5
• Never use doxycycline or TMP-SMX as monotherapy for cellulitis—their activity against beta-hemolytic streptococci is unreliable 2, 3

---

Treatment for Penicillin Allergy

For patients with penicillin allergy, clindamycin is the preferred alternative.

Penicillin-Allergic Patients

• Clindamycin 300-450 mg orally every 6 hours for 5 days 2, 3
• Provides coverage for both streptococci and MRSA without requiring combination therapy 2
• Cross-reactivity between penicillins and cephalosporins is only 2-4%, so cephalexin can often be used safely in penicillin-allergic patients except those with immediate hypersensitivity reactions 2

Severe Penicillin and Cephalosporin Allergy

• Clindamycin 300-450 mg orally every 6 hours (if local resistance <10%) 2
• Linezolid 600 mg orally twice daily (expensive, reserved for complicated cases) 2
• Levofloxacin 500 mg daily or moxifloxacin (reserve fluoroquinolones for beta-lactam allergies) 2

---

Hospitalization and IV Therapy

Indications for Hospitalization 2, 3

• Systemic inflammatory response syndrome (SIRS) (fever >38°C, tachycardia >90 bpm, tachypnea >24 rpm)
• Hypotension or hemodynamic instability
• Altered mental status or confusion
• Severe immunocompromise or neutropenia
• Concern for deeper or necrotizing infection
• Failure of outpatient treatment

IV Antibiotic Regimens for Hospitalized Patients

For Uncomplicated Cellulitis Requiring Hospitalization (No MRSA Risk Factors)

• Cefazolin 1-2 g IV every 8 hours (preferred IV beta-lactam) 2
• Oxacillin 2 g IV every 6 hours (alternative) 2

For Complicated Cellulitis with MRSA Risk Factors

• Vancomycin 15-20 mg/kg IV every 8-12 hours (first-line, A-I evidence) 2, 3
• Linezolid 600 mg IV twice daily (equally effective alternative, A-I evidence) 2
• Daptomycin 4 mg/kg IV once daily (A-I evidence) 2
• Clindamycin 600 mg IV every 8 hours (if local resistance <10%, A-III evidence) 2

For Severe Cellulitis with Systemic Toxicity or Suspected Necrotizing Fasciitis

Mandatory broad-spectrum combination therapy is required:

• Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 2
• Alternative: Linezolid 600 mg IV twice daily PLUS piperacillin-tazobactam 2
• Duration: 7-14 days (not the standard 5 days for uncomplicated cellulitis) 2

Transition to Oral Therapy

• Transition to oral antibiotics once clinical improvement is demonstrated, typically after a minimum of 4 days of IV treatment 2
• Options include cephalexin, dicloxacillin, or clindamycin 2

---

Essential Adjunctive Measures

These non-antibiotic interventions are critical and often neglected:

Elevation

• Elevate the affected extremity above heart level for at least 30 minutes three times daily to promote gravity drainage of edema and inflammatory substances 2, 3
• Elevation hastens improvement and is particularly important in older adults 2, 3

Treat Predisposing Conditions 2, 3

• Examine interdigital toe spaces for tinea pedis, fissuring, scaling, or maceration—treating these eradicates colonization and reduces recurrent infection
• Address venous insufficiency and lymphedema with compression stockings once acute infection resolves
• Manage chronic edema, obesity, and eczema

Consider Systemic Corticosteroids (Limited Evidence)

• Prednisone 40 mg daily for 7 days could be considered in non-diabetic adults to reduce inflammation, though evidence is limited 2, 3

---

Special Populations

Older Adults

• Identify and treat predisposing conditions common in older adults: venous insufficiency, tinea pedis, toe web abnormalities, and prior trauma 3
• Elevation is particularly important in older adults with venous insufficiency or lymphedema 3

Diabetic Foot Infections

• Diabetic foot infections are polymicrobial and require broader coverage and longer duration 2
• Mild infections: dicloxacillin, clindamycin, cephalexin, TMP-SMX, amoxicillin-clavulanate, or levofloxacin 2
• Moderate infections: amoxicillin-clavulanate, levofloxacin, ceftriaxone, ampicillin-sulbactam, or ertapenem 2
• Severe infections: piperacillin-tazobactam, imipenem-cilastatin, or vancomycin plus ceftazidime ± metronidazole 2

Pediatric Patients

• For children >8 years requiring MRSA coverage: clindamycin 10-13 mg/kg/dose every 6-8 hours (if local resistance <10%) OR TMP-SMX 4-6 mg/kg/dose twice daily PLUS a beta-lactam 2
• For hospitalized children: vancomycin 15 mg/kg IV every 6 hours (first-line, A-II evidence) 2
• Never use doxycycline in children <8 years due to tooth discoloration and bone growth effects 2, 5

---

Prevention of Recurrent Cellulitis

For patients with 3-4 episodes per year despite treating predisposing factors:

• Consider prophylactic antibiotics: oral penicillin V 250 mg twice daily or erythromycin 250 mg twice daily 2, 3
• Annual recurrence rates are 8-20% in patients with previous leg cellulitis 2

---

Common Pitfalls to Avoid

• Don't extend treatment unnecessarily beyond 5 days if clinical improvement has occurred—this increases antibiotic resistance without improving outcomes 2, 3
• Don't automatically add MRSA coverage for typical nonpurulent cellulitis without specific risk factors—this represents overtreatment 2, 3
• Don't use doxycycline or TMP-SMX as monotherapy—their activity against streptococci is unreliable 2, 3
• Don't delay surgical consultation if any signs of necrotizing infection are present—these infections progress rapidly 2
• Don't forget to examine interdigital toe spaces in lower-extremity cellulitis 2, 3
• Don't overlook the importance of elevation, especially in older adults 2, 3